{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&houseId=1&answeringDeptSortName=Health+and+Social+Care&_metadata=all&max-answer.dateOfAnswer=2023-09-19", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&_page=0&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "items" : [{"_about" : "http://data.parliament.uk/resources/1660723", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660723/answer", "answerText" : {"_value" : "

Of the 221 COVID-19 related claims rejected due to not meeting the 60% disability threshold, as of 1 September 2023, only nine, or 4%, potentially would have met a disability threshold of 50%; 34, or 15%, potentially would have met a disability threshold of 40%; 73, or 33%, potentially would have met a disability threshold of 30%; and 116, or 53%, potentially would have met a disability threshold of 20%. The data for lower thresholds is cumulative and includes claims that would meet a higher threshold.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T14:34:27.897Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Damage Payment Scheme: Coronavirus"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 11 September to Question 197988 on Vaccine Damage Payment Scheme: Coronavirus, how many and what proportion of the 221 claims rejected due to not meeting the 60% disability threshold would have met a disability threshold of (a) 50%, b) 40%, c) 30% and (d) 20%.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/242", "label" : {"_value" : "Biography information for Sir Christopher Chope"} } , "tablingMemberConstituency" : {"_value" : "Christchurch"} , "tablingMemberPrinted" : [{"_value" : "Sir Christopher Chope"} ], "uin" : "199534"} , {"_about" : "http://data.parliament.uk/resources/1660727", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660727/answer", "answerText" : {"_value" : "

We are concerned about the rise in the number of young people using vapes. There is well established concern about the addictive harms and risks from vaping, specifically associated with children and young people. Nicotine is highly addictive and there are unanswered questions on the effects of longer-term use.<\/p>

That is why the Government ran a call for evidence on youth vaping which closed on 6 June 2023. This will identify opportunities to reduce the number of children accessing and using vaping products and explore where the government can go further to protect children from the harms of vaping.<\/p>

We will respond to the call for evidence in due course.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4679", "label" : {"_value" : "Biography information for Neil O'Brien"} } , "answeringMemberConstituency" : {"_value" : "Harborough"} , "answeringMemberPrinted" : {"_value" : "Neil O'Brien"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T12:21:27.5Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Electronic Cigarettes: Young People"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the potential health implications of increases in the number of young people using vapes.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1409", "label" : {"_value" : "Biography information for Mr Gregory Campbell"} } , "tablingMemberConstituency" : {"_value" : "East Londonderry"} , "tablingMemberPrinted" : [{"_value" : "Mr Gregory Campbell"} ], "uin" : "199542"} , {"_about" : "http://data.parliament.uk/resources/1660728", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660728/answer", "answerText" : {"_value" : "

The information requested is currently not held centrally. The Department is monitoring demand for GLP1-RA medication using prescriptions data from the NHS Business Services Authority.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T15:57:51.727Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent estimate he has made of the number and proportion of people with type 2 diabetes who will be affected by the shortage of GLP1-RA medications.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4638", "label" : {"_value" : "Biography information for Mr Tanmanjeet Singh Dhesi"} } , "tablingMemberConstituency" : {"_value" : "Slough"} , "tablingMemberPrinted" : [{"_value" : "Mr Tanmanjeet Singh Dhesi"} ], "uin" : "199596"} , {"_about" : "http://data.parliament.uk/resources/1660798", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660798/answer", "answerText" : {"_value" : "

The following table shows for the years 2018/19 to 2022/23 the number of students who received an element of funding from the NHS Learning Support Fund, together with the number of students who received available childcare component and its corresponding expenditure:<\/p>

Financial Year<\/p><\/td>

2018/19<\/p><\/td>

2019/20<\/p><\/td>

2020/21<\/p><\/td>

2021/22<\/p><\/td>

2022/23<\/p><\/td><\/tr>

Students who Received an Element of Funding<\/p><\/td>

14,067<\/p><\/td>

26,382<\/p><\/td>

110,923<\/p><\/td>

130,213<\/p><\/td>

133,658<\/p><\/td><\/tr>

Students in Receipt of Child Dependants Allowance (CDA) or Parental Support (PS)<\/p><\/td>

8,014<\/p><\/td>

14,013<\/p><\/td>

36,192<\/p><\/td>

34,034<\/p><\/td>

35,649<\/p><\/td><\/tr>

CDA and PS Expenditure (£)<\/p><\/td>

5,908,671<\/p><\/td>

11,700,520<\/p><\/td>

35,068,824<\/p><\/td>

49,751,801<\/p><\/td>

52,565,170<\/p><\/td><\/tr><\/tbody><\/table>

<\/p>

Source: NHS Business Services Authority<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T15:14:32.13Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "NHS Learning Support Fund"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much his Department spent on Parental Support from the NHS Learning Support Fund in each of the last five years; and how many people have (a) made a claim and (b) been eligible for support under that scheme in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4088", "label" : {"_value" : "Biography information for Stella Creasy"} } , "tablingMemberConstituency" : {"_value" : "Walthamstow"} , "tablingMemberPrinted" : [{"_value" : "Stella Creasy"} ], "uin" : "199572"} , {"_about" : "http://data.parliament.uk/resources/1660799", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660799/answer", "answerText" : {"_value" : "

Suggested reply<\/strong><\/p>

The following table shows the breakdown of funding offered to parents across the Social Work Bursary scheme:<\/p>

Financial Year<\/p><\/td>

Number of students in receipt of Parent Learning Allowance<\/p><\/td>

Parent Learning Allowance Expenditure (£)<\/p><\/td>

Number of students in receipt of Childcare Allowance<\/p><\/td>

Childcare Allowance Expenditure (£)<\/p><\/td><\/tr>

2018/19<\/p><\/td>

1,239<\/p><\/td>

1,236,341<\/p><\/td>

567<\/p><\/td>

2,114,319<\/p><\/td><\/tr>

2019/20<\/p><\/td>

1,256*<\/p><\/td>

1,211,047<\/p><\/td>

630*<\/p><\/td>

2,124,705<\/p><\/td><\/tr>

2020/21<\/p><\/td>

1,175<\/p><\/td>

1,183,842<\/p><\/td>

573<\/p><\/td>

2,252,088<\/p><\/td><\/tr>

2021/22<\/p><\/td>

1,083<\/p><\/td>

1,061,297<\/p><\/td>

458<\/p><\/td>

1,941,897<\/p><\/td><\/tr>

2022/23<\/p><\/td>

958<\/p><\/td>

911,748<\/p><\/td>

389<\/p><\/td>

1,484,316<\/p><\/td><\/tr><\/tbody><\/table>

Source: NHS Business Services Authority (NHS BSA)<\/p>

Note: NHS BSA cannot give a count of applications that were deemed ineligible for the parent learning allowance or childcare allowance, as they do not directly record this in their systems. The information for the 2019/20 financial year contains data from two different IT systems with no unique identifiers, so there is a possibility of duplication in the count of students funded.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4527", "label" : {"_value" : "Biography information for Helen Whately"} } , "answeringMemberConstituency" : {"_value" : "Faversham and Mid Kent"} , "answeringMemberPrinted" : {"_value" : "Helen Whately"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T19:09:55.713Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Social Work: Training"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how much his Department spent on the Childcare Allowance and Parents\u2019 Learning Allowance of the Social Work Bursary in each of the last five years; and how many people have (a) made a claim and (b) been eligible for support under that scheme in each of the last five years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4088", "label" : {"_value" : "Biography information for Stella Creasy"} } , "tablingMemberConstituency" : {"_value" : "Walthamstow"} , "tablingMemberPrinted" : [{"_value" : "Stella Creasy"} ], "uin" : "199573"} , {"_about" : "http://data.parliament.uk/resources/1660807", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660807/answer", "answerText" : {"_value" : "

We are aware of a supply issue with Ozempic. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert with advice for healthcare professionals on how to manage patients requiring this medicine. Our guidance is clear that glucagon-like peptide 1 receptor agonist medicines, such as Ozempic, that are solely licensed to treat Type 2 diabetes should only be used for that purpose and should not be routinely prescribed for weight loss.<\/p>

The General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have also issued a joint statement stressing the importance of health and care professionals meeting regulatory standards in relation to these medicines. We have also added some of these products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.<\/p>

We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for patients in the UK, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "199679"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T09:35:57.177Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to increase stocks of diabetes medication.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4828", "label" : {"_value" : "Biography information for Paula Barker"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Paula Barker"} ], "uin" : "199678"} , {"_about" : "http://data.parliament.uk/resources/1660809", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660809/answer", "answerText" : {"_value" : "

We are aware of a supply issue with Ozempic. We have issued guidance in the form of Medicine Supply Notifications and, on 18 July 2023, issued a National Patient Safety Alert with advice for healthcare professionals on how to manage patients requiring this medicine. Our guidance is clear that glucagon-like peptide 1 receptor agonist medicines, such as Ozempic, that are solely licensed to treat Type 2 diabetes should only be used for that purpose and should not be routinely prescribed for weight loss.<\/p>

The General Pharmaceutical Council, General Medical Council, Health and Care Professions Council, Nursing and Midwifery Council and Pharmaceutical Society of Northern Ireland have also issued a joint statement stressing the importance of health and care professionals meeting regulatory standards in relation to these medicines. We have also added some of these products to the list of medicines that cannot be exported from, or hoarded in, the United Kingdom.<\/p>

We are continuing to work closely with manufacturers and others working in the supply chain to help ensure the continued supply of these medicines for patients in the UK, for example by asking suppliers to expedite deliveries. We have provided advice for healthcare professionals on how to manage patients requiring this medicine whilst there are shortages and are keeping this under review as the situation evolves. If any patient is concerned about their treatment, they should discuss this with their clinician at the earliest opportunity.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "199678"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T09:35:57.24Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes: Drugs"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what steps he is taking to restrict off-label prescription of diabetes medication.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4828", "label" : {"_value" : "Biography information for Paula Barker"} } , "tablingMemberConstituency" : {"_value" : "Liverpool, Wavertree"} , "tablingMemberPrinted" : [{"_value" : "Paula Barker"} ], "uin" : "199679"} , {"_about" : "http://data.parliament.uk/resources/1660814", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660814/answer", "answerText" : {"_value" : "

From 1 October 2021 to 1 September 2023, the NHS Business Services Authority has received 6,809 claims relating to COVID-19 vaccinations, and 251 claims relating to vaccines for other illnesses.<\/p>

Of these claims, 3,933 are currently awaiting a final decision; of which, 3,796 are related to vaccines for COVID-19 and 137 are related to vaccines for other illnesses. These 137 are broken down per vaccine as follows:<\/p>

- 35 are adult flu<\/p>

- 33 are unidentified/unclear due to multiple types of vaccinations<\/p>

- 17 are diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (DTaP/IPV/Hib)<\/p>

- 15 are measles, mumps and rubella (MMR)<\/p>

- 9 are human papillomavirus (HPV)<\/p>

<\/p>

The following vaccines have received fewer than five claims and the exact amount cannot be disclosed as this information may make individuals personally identifiable in the public domain:<\/p>

- Influenza<\/p>

- Swine flu (Pandemic influenza A (H1N1) 2009)<\/p>

- Polio (Poliomyelitis - orally administered)<\/p>

- Unidentified/unclear<\/p>

- Haemophilus influenzae type b, meningococcal group C (Hib/Men C)<\/p>

- Haemophilus influenzae type b (Hib)<\/p>

- Meningococcal group C (Men C, Men ACWY)<\/p>

- Pneumococcal (PCV)<\/p>

- Tuberculosis (TB)<\/p>

- Tetanus<\/p>

- Mumps<\/p>

- Meningococcal group B (Men B)<\/p>

- Diphtheria, tetanus, pertussis and polio (DTaP/IPV)<\/p>

- Rubella (German measles)<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T14:36:20.357Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccine Damage Payment Scheme"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, how many claims under the Vaccine Damage Payments Scheme have been received between October 2021 and September 2023; how many of these claims relate to vaccines for (a) Covid-19 and (b) other illnesses; and how many claims are still awaiting a final decision per vaccine.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/242", "label" : {"_value" : "Biography information for Sir Christopher Chope"} } , "tablingMemberConstituency" : {"_value" : "Christchurch"} , "tablingMemberPrinted" : [{"_value" : "Sir Christopher Chope"} ], "uin" : "199535"} , {"_about" : "http://data.parliament.uk/resources/1660874", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660874/answer", "answerText" : {"_value" : "

The information is not held in the format requested as the research & development budget is not separated from the wider budget of the Vaccine Development and Evaluation Centre.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T16:46:23.693Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "UK Health Security Agency: Finance"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what the R&D budget is of the UK Health Security Agency Vaccine Development and Evaluation Centre.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4124", "label" : {"_value" : "Biography information for Chi Onwurah"} } , "tablingMemberConstituency" : {"_value" : "Newcastle upon Tyne Central"} , "tablingMemberPrinted" : [{"_value" : "Chi Onwurah"} ], "uin" : "199593"} , {"_about" : "http://data.parliament.uk/resources/1660876", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1660876/answer", "answerText" : {"_value" : "

We have no plans to make such an estimate.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4492", "label" : {"_value" : "Biography information for Maria Caulfield"} } , "answeringMemberConstituency" : {"_value" : "Lewes"} , "answeringMemberPrinted" : {"_value" : "Maria Caulfield"} , "dateOfAnswer" : {"_value" : "2023-09-19", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-09-19T14:37:19.183Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-09-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Treatments: Children"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will make an estimate of the potential cost of providing (a) anti-inflammatory and (b) immunomodulatory treatment to young people where the potential merits of doing so outweigh the potential harms.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4244", "label" : {"_value" : "Biography information for Jonathan Ashworth"} } , "tablingMemberConstituency" : {"_value" : "Leicester South"} , "tablingMemberPrinted" : [{"_value" : "Jonathan Ashworth"} ], "uin" : "199656"} ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?min-answer.dateOfAnswer=2018-12-13&_page=1&houseId=1&answeringDeptSortName=Health+and+Social+Care&max-answer.dateOfAnswer=2023-09-19", "page" : 0, "startIndex" : 1, "totalResults" : 42212, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }